BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Tuesday, April 23, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Oct. 22, 2020
View Archived Issues
A stinging defeat for infections
Read More
Researchers develop a new murine model of seizures with Chd8 haploinsufficiency
Read More
DUSP6 is implicated in vascular disease and may be a therapeutic target
Read More
Abpro completes dosing in phase I trial of ABP-300 for COVID-19
Read More
Optimization of selective antagonists of vasopressin V1A receptor derived from triazolobenzazepines
Read More
Hyaluronan is present in the alveolar spaces in lungs of patients with fatal COVID-19
Read More
SARS-CoV-2 RNA genome can be targeted using small-molecule binders and RIBOTAC degraders
Read More
Phase III study of masitinib in severe asthma uncontrolled by ICS meets primary endpoint
Read More
Oxeia initiates phase II study of OXE-103 for concussions
Read More
Storm Therapeutics patents METTL3 inhibitors
Read More
Centauri Therapeutics divulges new antibacterials
Read More
Array BioPharma presents new PTPN11 inhibitors
Read More
First patient enrolled in MERKLIN 2 trial of domatinostat plus avelumab in MCC
Read More
New CDK inhibitors presented by Aurigene Discovery Technologies
Read More
Sorrento Therapeutics patents CD38-targeting antibodies
Read More
Poseida and TScan collaborate to develop TCR-T cell therapies for treatment of COVID-19
Read More
Second part of daratumumab CASSIOPEIA study in multiple myeloma meets primary endpoint
Read More
First-in-human injection of [68]Ga-NT-20.3 found to be well-tolerated without AEs
Read More
Phase I data presented for RP-L201 in patients with LAD-I
Read More
Gene therapy approaches tackle multiple forms of blindness
Read More
FDA clears Cyclo to open global phase III trial of Trappsol Cyclo for NPC in U.S.
Read More
MAb 5D3-mertansine antibody-drug conjugate shows efficacy in prostate cancer mouse models
Read More
Ultimovacs reports 5-year OS data from phase I trial of UV-1 in NSCLC
Read More
Nanoform targets initiation of first-in-human trial of nanoformed piroxicam before year-end
Read More
Daiichi initiates phase I trial of DS-1055 in advanced or metastatic solid tumors
Read More